Description

Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1].—Cancer-Kinase/protease–C50H78N10O11—-[1]Dillon PM, et al. Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data. Breast Cancer (Dove Med Press). 2020 Apr 3;12:69-75. –160212-35-1–995.21—-CC(C)C[C@@H](C(O)=O)NC([C@@H](NC([C@H](C)NC([C@H](CC(C)C)NC([C@H](CO)NC(CNC([C@@H](NC([C@H]([C@@H](C)CC)NC([C@@H](N)CCCCN)=O)=O)CC1=CC=CC=C1)=O)=O)=O)=O)=O)CC2=CC=CC=C2)=O–Cancer–H2O–EGFR–ErbB2/HER2–JAK/STAT Signaling;Protein Tyrosine Kinase/RTK–Peptides